Neuralink

Elon Musk’s biotech startup Neuralink announced last week that it has obtained approval from an independent review board to initiate recruitment for its inaugural human trial involving a brain implant designed for individuals with paralysis.

Elon Musk’s brain chip company said Thursday that the U.S. Food and Drug Administration has given it the green light for its first human clinical trial, marking a key milestone following struggles to win approval.

This year’s demonstration focused on the technology behind Elon Musk’s brain-computer interface company and its potentially imminent arrival in human heads.